Synergy of genes and nutrients: the case of homocysteine
Author:
- 1 November 2006
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Clinical Nutrition and Metabolic Care
- Vol. 9 (6) , 748-756
Abstract
Folic acid is now considered an important functional food component: it lowers potentially toxic homocysteine, prevents birth defects and modulates the risk of several cancers. The complexity of interactions involved, however, means we still have much to learn about the role of folate and homocysteine in both health and disease. This review examines the emergence of homocysteine as a public health issue, and places this in context by exploring recent developments in the field of homocysteine as a vasculo, neuro and embryotoxic thiol. The paper also examines the homocysteine nexus in relation to mood disorders and cancer. It ends with an assessment of the issues associated with government-mandated folate fortification. Folate fortification as a population measure may mask B12 deficiency, affect antiepileptic drug seizure control, and influence the genetic selection of a potentially deleterious genotype, albeit over a number of generations. It is likely that only large studies with a comprehensive battery of endpoints that fully address the complexity of nutrient-gene and gene-gene interactions will be able to answer all the necessary questions fully.Keywords
This publication has 66 references indexed in Scilit:
- Meta-analysis of MTHFR 677C→ T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate?BMJ, 2005
- Homocysteine, MTHFR and risk of venous thrombosis: a meta‐analysis of published epidemiological studiesJournal of Thrombosis and Haemostasis, 2005
- Evolutionary Health PromotionPreventive Medicine, 2002
- The Significance of Wheat in the Dakota Territory, Human Evolution, Civilization, and Degenerative DiseasesPerspectives in Biology and Medicine, 2001
- Polymorphisms of Methylenetetrahydrofolate Reductase and Other Enzymes: Metabolic Significance, Risks and Impact on Folate RequirementThe Journal of Nutrition, 1999
- Common Methylenetetrahydrofolate Reductase Gene Mutation Leads to Hyperhomocysteinemia but Not to Vascular DiseaseCirculation, 1998
- Review Paleolithic nutrition revisited: A twelve-year retrospective on its nature and implicationsEuropean Journal of Clinical Nutrition, 1997
- A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular DiseaseJAMA, 1995
- Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifidaThe Lancet, 1995
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995